FPN || Women's Health

Bisphosphonates may protect against endometrial cancer

Posted on: 22/12/2014 - 05:01

The use of nitrogenous bisphosphonates was associated with a nearly 50% reduction in the incidence of endometrial cancer among women in the PLCO, or Prostate, Lung, Colorectal, and Ovarian Cancer...

Field of Interest: Pulmonology
Type: News Item

Bisphosphonates may protect against endometrial cancer

Posted on: 22/12/2014 - 05:01

The use of nitrogenous bisphosphonates was associated with a nearly 50% reduction in the incidence of endometrial cancer among women in the PLCO, or Prostate, Lung, Colorectal, and Ovarian Cancer...

Field of Interest: Oncology
Type: News Item

FDA approves PARP-inhibitor for ovarian cancer

Posted on: 19/12/2014 - 18:41

Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has been approved for treating advanced ovarian cancer associated with defective BRCA genes, the Food and Drug Administration announced on...

Field of Interest: Pulmonology
Type: News Item

FDA approves PARP-inhibitor for ovarian cancer

Posted on: 19/12/2014 - 18:41

Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has been approved for treating advanced ovarian cancer associated with defective BRCA genes, the Food and Drug Administration announced on...

Field of Interest: Oncology
Type: News Item

Preeclampsia in SLE ups CVD risk

Posted on: 18/12/2014 - 18:13

Women with lupus and a history of preeclampsia have almost fourfold higher odds of subsequent heart disease as measured by coronary artery calcium than do women with the disease who never had...

Field of Interest: Rheumatology
Type: News Item

Preeclampsia in SLE ups CVD risk

Posted on: 18/12/2014 - 18:13

Women with lupus and a history of preeclampsia have almost fourfold higher odds of subsequent heart disease as measured by coronary artery calcium than do women with the disease who never had...

Field of Interest: Pulmonology
Type: News Item

Genetic test predicts 10-year risk of DCIS recurrence

Posted on: 17/12/2014 - 16:28

SAN ANTONIO – A genetic assay specific for ductal cancer in situ accurately predicted 10-year recurrence risk in women who underwent breast-conserving surgery as treatment for the disease. Women...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More